Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Products
  • Duloxetine Delayed-Release Capsules USP
Where it was sold

Nationwide in the USA

Nationwide

Units affected
165,761 90-count bottles
About this recall
Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. by Towa Pharmaceutical Eurpoe S.L., Martorelles, (Barcelona), Spain, Dist. by. Breckenridge Pharmaceutical, Inc., Berkely Heights, NJ 07922, NDC 51991-748-90.